Evidence for a Common, Saturable, Triglyceride Removal Mechanism for Chylomicrons and Very Low Density Lipoproteins in Man
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Hypertriglyceridemic subjects were fed diets in which dietary fat calories were held constant, but carbohydrate calories were varied. Three subjects with fasting chylomicronemia (Type V) were given less carbohydrate and four subjects without fasting chylomicronemia (Type IV) were fed diets with more calories as carbohydrate. The restricted carbohydrate intake led to disappearance of chylomicronemia in those subjects who had chylomicronemia on a normal diet (Type V to IV). In those subjects without chylomicronemia, chylomicronemia appeared in response to increased carbohydrate intake (Type IV to V). Thus chylomicron concentrations in plasma were altered even though fat intake and presumably chylomicron input into plasma was kept constant. These findings provide evidence for saturation of chylomicron removal mechanisms by alteration of endogenous triglyceride-rich lipoprotein concentrations. They suggest that chylomicrons compete with very low density lipoproteins for similar removal mechanisms. The relationship between endogenous triglyceride concentration and the lipolytic activity in plasma following heparin was then evaluated with the use of long-term heparin infusions to release and maintain lipolytic activity in the circulation. 10 subjects were placed on fatfree diets to remove circulating dietary fat. The plasma lipolytic rate during the heparin infusion was measured consecutively on different days in individuals whose triglyceride concentrations were varied by either increasing or decreasing calories. The lipolytic rate was curvilinearly related to the plasma triglyceride concentrations. This curvilinear relationship followed Michaelis-Menton saturation kinetics over a wide range of triglyceride concentrations on fat-free, high-carbohydrate diets, in multiple studies in a group of individuals. These studies suggest that endogenous and exogenous triglyceride compete for a common, saturable, plasma triglyceride removal system related to lipoprotein lipase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In patients with severe or very severe triglyceride levels (Ն1000 mg/dl), the LpL removal system is saturated (74).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [74]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Factors that reduce VLDL clearance can raise triglyceride concentrations in those with high baseline levels (eg, usually Ͼ500 mg/dL, because of the competition of VLDL and chylomicrons for a common saturable removal mechanism).97”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [97]
Experimental — accuracy not yet measuredIn the citing paper
“In addition, chylomicrons compete with endogenous VLDL for the action of LPL [20].”
From Dyslipidemia in obesity: Mechanisms and potential targets (2013) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,910
Electrophoretic separation of plasma lipoproteins in agarose gel
Noble, R. P. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42680-x · Cited by 1,307
Classification of Hyperlipidaemias and Hyperlipoproteinaemias ,
(1972) · Standard Methods of Clinical Chemistry · doi:10.1016/b978-0-12-609107-6.50016-7 · Cited by 820
Editorial: A System for Phenotyping Hyperlipoproteinemia
FREDRICKSON, D. S., & LEES, R. S. (1965) · Circulation · doi:10.1161/01.cir.31.3.321 · Cited by 507
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701122760206 · Cited by 499
Lipolytic activity of post-heparin plasma in hyperglyceridemia
Fredrickson, D. S., Ono, K., & Davis, L. L. (1963) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40361-x · Cited by 370
Havel, R. J., Kane, J. P., Balasse, E. O., Segel, N., & Basso, L. V. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106422 · Cited by 336
The Metabolic Basis of Inherited Disease
Martin, D. B. (1967) · Archives of Internal Medicine · doi:10.1001/archinte.1967.00300020128027 · Cited by 320
Classification of Hyperlipidemias and Hyperlipoproteinemias
(1972) · Circulation · doi:10.1161/01.cir.45.2.501 · Cited by 257
Kinetics of triglyceride turnover of very low density lipoproteins of human plasma
Reaven, G. M., Hill, D. B., Gross, R. C., & Farquhar, J. W. (1965) · Journal of Clinical Investigation · doi:10.1172/jci105290 · Cited by 221
Research works printed but not linked: 2
- [10]10. Boberg, J. 1971. Mechanisms of hypertriglyceridemia in man. Thesis. Acta Universitatis Upsaliensis, Uppsala, Sweden.
- [19]19. Snedecor, G. W., and W. G. Cochran. 1967. Statistical Methods. The Iowa State University Press, Ames. 6th edition. 456.
Cited by
Items 101–200 of 483
Effects of glucose ingestion on postprandial lipemia and triglyceride clearance in humans.
Cohen, J., & Berger, G. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42827-5 · Cited by 84
Chan, D. T., Dogra, G. K., Irish, A. B., Ooi, E. M. M., Barrett, P. H. R., Chan, D. C., & Watts, G. F. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p900003-jlr200 · Cited by 95
Chylomicronemia Syndrome in Diabetes Mellitus
Chait, A., Robertson, H. T., & Brunzell, J. D. (1981) · Diabetes Care · doi:10.2337/diacare.4.3.343 · Cited by 83
Self-citationAldred, H. E., Hardman, A. E., & Taylor, S. (1995) · Metabolism · doi:10.1016/0026-0495(95)90172-8 · Cited by 105
Williams, C. M., Moore, F., Morgan, L., & Wright, J. (1992) · British Journal of Nutrition · doi:10.1079/bjn19920123 · Cited by 81
Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase
Xiang, S.-Q., Cianflone, K., Kalant, D., & Sniderman, A. D. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33411-8 · Cited by 82
de Bruin, T. W. A., Brouwer, C., Trip, M. V. L.-S., Jansen, H., & Erkelens, D. W. (1993) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/58.4.477 · Cited by 81
Hokanson, J. E. (1997) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02827239 · Cited by 80
Westphal, S., Orth, M., Ambrosch, A., Osmundsen, K., & Luley, C. H. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.4.914 · Cited by 87
Koutsari, C., Karpe, F., Humphreys, S. M., Frayn, K. N., & Hardman, A. E. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.095553 · Cited by 79
Potts, J. L., Coppack, S. W., Fisher, R. M., Humphreys, S. M., Gibbons, G. F., & Frayn, K. N. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.4.e588 · Cited by 81
Adrenergic effects on plasma lipoprotein metabolism: Speculation on mechanisms of action
Sacks, F. M., & Dzau, V. J. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90163-4 · Cited by 79
PYKÄLISTÖ, O., GOLDBERG, A. P., & BRUNZELL, J. D. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-43-3-591 · Cited by 77
Self-citationRegulation of chylomicron production in humans
Xiao, C., & Lewis, G. F. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.019 · Cited by 92
Katsanos, C. S., Grandjean, P. W., & Moffatt, R. J. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00243.2003 · Cited by 93
“Because it is known that the initial TG concentration is a determining factor of the magnitude of PPL (4), and because exercise has previously been shown to affect plasma TG under conditions similar to those of this study (41), the fasting TG Table 3.”
ResultBrunzell, J. D., Porte, D., & Bierman, E. L. (1975) · Metabolism · doi:10.1016/0026-0495(75)90149-3 · Cited by 77
Self-citationKEKKI, M. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90102-1 · Cited by 80
Diurnal triglyceride profiles: a novel approach to study triglyceride changes
Cabezas, M. C., Halkes, C. J. M., Meijssen, S., van Oostrom, A. J. H. H. M., & Erkelens, D. W. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00554-2 · Cited by 84
Studies on the etiology of the hyperlipemia in rats fed an atherogenic diet
Kris-Etherton, P. M., & Cooper, A. D. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39793-5 · Cited by 75
Chong, M. F. F., Fielding, B. A., & Frayn, K. N. (2007) · Proceedings of the Nutrition Society · doi:10.1017/s0029665107005290 · Cited by 73
“It is speculated that the higher affinity of lipoprotein lipase for chylomicrons than for VLDL may be a factor affecting the rate of TAG clearance in these lipoprotein fractions when these particles compete for hydrolysis by lipoprotein lipase (Brunzell et al. 1973).”
BackgroundCarr, M. C., Hokanson, J. E., Deeb, S. S., Purnell, J. Q., Mitchell, E. S., & Brunzell, J. D. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.11.2701 · Cited by 75
Self-citationBest practice in primary care pathology: review 3
Smellie, W. S. A., Forth, J., Bareford, D., Twomey, P. J., Galloway, M. J., Logan, E. C. M., Smart, S., Reynolds, T., & Waine, C. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.200x.033944 · Cited by 74
The interaction of familial and secondary causes of hypertriglyceridemia: role in pancreatitis
Brunzell, J. D., & Schrott, H. G. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2012.06.005 · Cited by 71
Self-citationMagkos, F. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.02.003 · Cited by 83
Childs, M. T., Bowlin, J. A., Ogilvie, J. T., Hazzard, W. R., & Albers, J. J. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90119-2 · Cited by 81
Self-citationPatsch, W., Gotto, A. M., & Patsch, J. R. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67556-8 · Cited by 76
Karpe, F., & Hultin, M. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39742-x · Cited by 70
Severe hypertriglyceridemia: role of familial and acquired disorders.
Chait, A., & Brunzell, J. D. (1983) · Metabolism · doi:10.1016/0026-0495(83)90184-1 · Cited by 69
Self-citationBozzetto, L., Annuzzi, G., Corte, G. D., Patti, L., Cipriano, P., Mangione, A., Riccardi, G., & Rivellese, A. A. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.012 · Cited by 76
Avogaro, P., & Cazzolato, G. (1975) · Metabolism · doi:10.1016/0026-0495(75)90062-1 · Cited by 69
Cabezas, M. C., de Bruin, T. W., Kock, L. A., Kortlandt, W., Trip, M. V. L.-S., Jansen, H., & Erkelens, D. W. (1993) · Metabolism · doi:10.1016/0026-0495(93)90109-2 · Cited by 74
Type III Hyperlipoproteinemia: Diagnosis in Whole Plasma by Apolipoprotein-E Immunoassay
KUSHWAHA, R. S., HAZZARD, W. R., WAHL, P. W., & HOOVER, J. J. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-5-509 · Cited by 69
Self-citationAdiels, M., Matikainen, N., Westerbacka, J., Söderlund, S., Larsson, T. P., Olofsson, S., Borén, J., & Taskinen, M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.02.001 · Cited by 73
Receptor-mediated mechanisms of lipoprotein remnant catabolism
Chappell, D. A., & Medh, J. D. (1998) · Progress in Lipid Research · doi:10.1016/s0163-7827(98)00017-4 · Cited by 88
Nozaki, S., Garg, A., Vega, G., & Grundy, S. M. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.3.638 · Cited by 75
Dietary ethanol is associated with reduced lipolysis of intestinally derived lipoproteins.
Pownall, H. J. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39917-x · Cited by 67
Katsanos, C. S. (2006) · Sports Medicine · doi:10.2165/00007256-200636070-00001 · Cited by 85
Recent concepts of intestinal fat absorption
Ockner, R. K., & Isselbacher, K. J. (2005) · Springer eBooks · doi:10.1007/bfb0027662 · Cited by 66
The Latest on the Effect of Prior Exercise on Postprandial Lipaemia
Maraki, M. I., & Sidossis, L. S. (2013) · Sports Medicine · doi:10.1007/s40279-013-0046-9 · Cited by 65
Mattes, R. D. (2002) · Journal of Nutrition · doi:10.1093/jn/132.12.3656 · Cited by 75
Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia
Castro Cabezas, M., DE Bruin, T. W. A., Westerveld, H. E., Meijer, E., & Erkelens, D. W. (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00367.x · Cited by 65
Turner, J., Bierman, E. L., Brunzell, J., & Chait, A. (1979) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/32.5.1043 · Cited by 65
“units/rn’ per hour) designed to keep circulating enzyme levels maximally elevated ( 39 ).”
BackgroundMethodSelf-citationN-3 fatty acids and chylomicron metabolism in the rat
Harris, W. S., Hustvedt, B. E., Hagen, E., Green, M. H., Lu, G., & Drevon, C. A. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37258-8 · Cited by 64
Postprandial lipemia: effects of intermittent versus continuous exercise
GILL, J. M. R., MURPHY, M. H., & HARDMAN, A. E. (1998) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199810000-00008 · Cited by 65
Olefsky, J. M., Farquhar, J. W., & Reaven, G. M. (1974) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1974.tb00382.x · Cited by 64
Intravenous Lipids for Preterm Infants: A Review
Salama, G. S. A., Kaabneh, M. A. F., Almasaeed, M. N. O., & Alquran, M. I. A. (2015) · Clinical Medicine Insights Pediatrics · doi:10.4137/cmped.s21161 · Cited by 76
Etiology and risk of lactescent plasma and severe hypertriglyceridemia
Tremblay, K., Méthot, J., Brisson, D., & Gaudet, D. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.11.004 · Cited by 63
Heath, R. B., Karpe, F., Milne, R. W., Burdge, G. C., Wootton, S. A., & Frayn, K. N. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00409.2006 · Cited by 50
“chylomicron particles even during postprandial lipemia (7), VLDL particles compete with chylomicrons for clearance by lipoprotein lipase (4), and postprandial lipemia, to which VLDL-TG contributes significantly (6, 29), is a well-established risk factor for cardiovascular disease.”
BackgroundHuman triacylglycerol-rich lipoprotein subfractions as substrates for lipoprotein lipase
Fisher, R. M., Coppack, S. W., Humphreys, S. M., Gibbons, G. F., & Frayn, K. N. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06032-3 · Cited by 63
Circadian variation of postprandial lipemia
Romon, M., Fur, C. L., Lebel, P., Edmé, J.-L., Fruchart, J., & Dallongeville, J. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.4.934 · Cited by 72
“metabolic processing by lipolytic enzymes and cellular re- ceptors ( 19 , 20).”
BackgroundMechanism of intestinal lipoprotein overproduction in insulin resistant humans
Duez, H., Pavlic, M., & Lewis, G. F. (2008) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2008.05.013 · Cited by 67
Lipoprotein Physiology and Its Relationship to Atherogenesis
Ginsberg, H. N. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30322-0 · Cited by 74
DRUGS CAUSING DYSLIPOPROTEINEMIA
Donahoo, W. T., Kosmiski, L. A., & Eckel, R. H. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70033-5 · Cited by 66
Pathophysiology of lipoprotein transport
Brunzell, J. D., Chait, A., & Bierman, E. L. (1978) · Metabolism · doi:10.1016/0026-0495(78)90157-9 · Cited by 67
Self-citationDunn, F. L., Raskin, P., Bilheimer, D. W., & Grundy, S. M. (1984) · Metabolism · doi:10.1016/0026-0495(84)90122-7 · Cited by 68
Postabsorptive metabolism of dietary squalene
Gylling, H., & Miettinen, T. A. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90122-8 · Cited by 64
Chait, A., Hazzard, W. R., Albers, J. J., Kushwaha, R. P., & Brunzell, J. D. (1978) · Metabolism · doi:10.1016/0026-0495(78)90151-8 · Cited by 65
Self-citationModerate fish oil intake improves lipemic response to a standard fat meal: A study in 25 healthy men
Brown, A. J., & Roberts, D. C. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.3.457 · Cited by 59
Effect of acarbose on postprandial lipid metabolism in type 2 diabetes mellitus
Kado, S., Murakami, T., Aoki, A., Nagase, T., Katsura, Y., Noritake, M., Matsuoka, T., & Nagata, N. (1998) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(98)00062-x · Cited by 62
Chylomicron triglyceride clearance: comparison of three assessment methods
Cohen, J. C. (1989) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/49.2.306 · Cited by 59
Walking During the Postprandial Period Decreases Alimentary Lipaemia
Hardman, A. E., & Aldred, H. E. (1995) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679500200111 · Cited by 52
Heterogeneity of primary lipoprotein lipase deficiency
Brunzell, J. D., Chait, A., Nikkilä, E. A., Ehnholm, C., Huttenen, J. K., & Steiner, G. A. (1980) · Metabolism · doi:10.1016/0026-0495(80)90106-7 · Cited by 59
Self-citationMajali, K. A., Cooper, M. B., Staels, B., Luc, G., Taskinen, M., & Betteridge, D. J. (2006) · Diabetologia · doi:10.1007/s00125-005-0092-4 · Cited by 63
“the precursor of LDL [7].”
Intestinal Metabolism of Lipids and Lipoproteins
Gangl, A., & Ockner, R. K. (1975) · Gastroenterology · doi:10.1016/s0016-5085(75)80063-1 · Cited by 63
Patsch, J. R. (1987) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(87)80023-x · Cited by 72
van Oostrom, A. J. H. H. M., Cabezas, M. C., Ribalta, J., Masana, L., Twickler, T. B., Remijnse, T. A. W., & Erkelens, D. W. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00732.x · Cited by 64
Characterization of chylomicron remnant clearance by retinyl palmitate label in normal humans.
Berr, F. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41517-2 · Cited by 55
Reduced triglyceride secretion: a metabolic consequence of chronic exercise.
Simonelli, C. M., & Eaton, R. P. (1978) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1978.234.3.e221 · Cited by 56
Chromosome abnormalities in familial hemophagocytic lymphohistiocytosis
Kletzel, M., Gollin, S. M., Gloster, E. S., Jimenez, J. F., Golladay, E. S., & Berry, D. H. (1986) · Cancer · doi:10.1002/1097-0142(19860601)57:11<2230::aid-cncr2820571126>3.0.co;2-5 · Cited by 11
Lipids and the Endothelium: Bidirectional Interactions
Goldberg, I. J., & Bornfeldt, K. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0365-1 · Cited by 59
“In vitro and in vivo data suggest that LpL is saturated at a substrate concentration of 5 μM (approximately 500 mg/dL) [27]; therefore, under most physiologic conditions, local LpL actions are highly dependent on the circulating triglyceride level.”
Background17 beta-Estradiol improves postprandial lipid metabolism in postmenopausal women
Westerveld, H. T. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.1.249 · Cited by 55
Glomset, J. A., Norum, K. R., Nichols, A. V., King, W. C., Mitchell, C. D., Applegate, K. R., Gong, E. L., & Gjone., E. (1975) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365517509108157 · Cited by 54
Meijssen, S., Cabezas, M. C., Twickler, T. B., Jansen, H., & Erkelens, D. W. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32015-0 · Cited by 53
Apolipoprotein B Metabolism: Tracer Kinetics, Models, and Metabolic Studies
Burnett, J. R., & Barrett, P. H. R. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360208951113 · Cited by 54
King, J. M., Crouse, J. R., Terry, J. G., Morgan, T. M., Spray, B. J., & Miller, N. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90298-4 · Cited by 54
Postprandial Inflammation: Targeting Glucose and Lipids
de Vries, M. A., Klop, B., Janssen, H. W., Njo, T. L., Westerman, E. M., & Cabezas, M. C. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_12 · Cited by 57
Pavlic, M., Valéro, R., Duez, H., Xiao, C., Szeto, L., Patterson, B. W., & Lewis, G. F. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.169383 · Cited by 51
Dunn, F. L. (1982) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31368-2 · Cited by 55
Obesity and post-prandial lipid metabolism. Feast or famine?
Martins, I. J., & Redgrave, T. G. (2004) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2003.10.006 · Cited by 60
Dullaart, R. P. F., Groener, J. E. M., Wijk, H. V., Sluiter, W. J., & Erkelens, D. W. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.5.614 · Cited by 58
Berr, F., Eckel, R., & Kern, F. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34315-7 · Cited by 51
Chait, A. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.02.010 · Cited by 58
Treatment options for hypertriglyceridemia: From risk reduction to pancreatitis
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., & Stalenhoef, A. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.002 · Cited by 50
Self-citationCabezas, M. C., Erkelens, D. W., Kock, L. A., & de Bruin, T. W. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb01059.x · Cited by 58
HAZZARD, W. R., O'DONNELL, T. F., & LEE, Y. L. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-2-141 · Cited by 50
Self-citationPlasma lipoproteins, lipid transport, and atherosclerosis: recent developments.
Miller, N. E. (1979) · Journal of Clinical Pathology · doi:10.1136/jcp.32.7.639 · Cited by 61
“…numerals refer to the lipoprotein phenotype according to the classification of the World Health Organization (1970) interfere with the catabolism of chylomicrons, probably by competing for common removal mechanisms (Brunzell et al., 1973), resulting in a combined elevation of both lipoproteins.”
MethodInsulin Resistance, Impaired Postprandial Lipid Metabolism and Abdominal Obesity
Frayn, K. N. (2002) · Medical Principles and Practice · doi:10.1159/000066414 · Cited by 70
Plasma Clearance of Fat Emulsion in Trauma and Sepsis: Use of a Three‐Stage Lipid Clearance Test
Robin, A. P., Nordenstrüm, J., ASKANAZI, J., Elwyn, D. H., Carpentier, Y., & Kinney, J. M. (1980) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860718000400514 · Cited by 49
Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families.
Sprecher, D. L., Knauer, S. L., Black, D. M., Kaplan, L. A., Akeson, A. A., Dusing, M., Lattier, D., Stein, E. A., Rymaszewski, M., & Wiginton, D. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115402 · Cited by 49
Karalis, D. G. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0462-y · Cited by 59
Shannon, K. A., Shannon, R. M., Clore, J. N., Gennings, C., Warren, B. J., & Potteiger, J. A. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.017 · Cited by 60
“In the postprandial state, lipoprotein lipase (LPL), which resides in the vascular endothelium of skeletal muscle, is responsible for the hydrolysis of circulating chylomicrons and very low-density lipoprotein, which compete in a shared lipolytic pathway [6-8].”
BackgroundZheng, C., Murdoch, S. J., Brunzell, J. D., & Sacks, F. M. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000203512.01007.3d · Cited by 48
Self-citationThe physiology of MASLD: molecular pathways between liver and adipose tissues
Lee, W., Kipp, Z. A., Bates, E. A., Pauss, S. N., Martinez, G. J., & Hinds, T. D. (2025) · Clinical Science · doi:10.1042/cs20257571 · Cited by 56
Postprandial lipid metabolism in relation to coronary heart disease
Karpe, F. (1997) · Proceedings of The Nutrition Society · doi:10.1079/pns19970067 · Cited by 59
“After a fatty meal, chylomicrons and VLDL mix in blood and, thus, compete for the same lipolytic pathway (Brunzell et al. 1973).”
BackgroundPostprandial plasma triglyceride and cholesterol responses to a low-fat meal
Olefsky, J. M., Crapo, P. A., & Reaven, G. M. (1976) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/29.5.535 · Cited by 53
Treatment of Hyperlipidemic Pancreatitis in Pregnancy With Total Parenteral Nutrition
Weinberg, R. B., Sitrin, M. D., Adkins, G. M., & Lin, C.-C. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80144-3 · Cited by 47
Chen, Y. D. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.2.347 · Cited by 48
Santos, R. D., Sposito, A. C., Ventura, L. I., César, L. A. M., Ramires, J. A. F., & Maranhão, R. C. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00721-9 · Cited by 46
HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome
Alcover, S., Ramos-Regalado, L., Girón, G., Muñoz‐García, N., & Vilahur, G. (2025) · Antioxidants · doi:10.3390/antiox14040434 · Cited by 57
“This process leads to the overproduction and release of hepatic VLDL (particularly larger and TG-rich VLDL) [125], which hinders the lipolysis of chylomicrons by competing at the LPL level [139].”
Hokanson, J. E., Brunzell, J. D., Jarvik, G. P., Wijsman, E. M., & Austin, M. A. (1999) · The American Journal of Human Genetics · doi:10.1086/302234 · Cited by 49
“1982), a saturable process that leads to the formation of remnant lipoproteins, which then may be degraded by the liver or converted to LDL particles (Brunzell et al. 1973).”
BackgroundSelf-citation
Metadata
- Authors
- Brunzell, J. D., Hazzard, W. R., Porte, D., & Bierman, E. L.
- Affiliations
- United States Department of Veterans Affairs (US)
- ORCID
- Brunzell, John D.
- Venue
- Journal of Clinical Investigation
- Published
- 1973-07-01
- Volume
- 52
- Issue
- 7
- Pages
- 1578-1585
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC302428
- OpenAlex
- W2077829695
- Cited by
- 484
- References
- 25
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 8 · 2020: 8 · 2019: 11 · 2018: 6 · 2017: 3 · 2016: 9 · 2015: 9 · 2014: 12 · 2013: 8 · 2012: 6
- FWCI
- 15.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- VLDL, triglyceride-rich lipoproteins, lipoprotein lipase, Michaelis-Menten kinetics, carbohydrate intake, dietary fat, heparin infusion, lipolysis
- MeSH terms
- Adult, Chylomicrons, Dietary Carbohydrates, Dietary Fats, Female, Heparin, Humans, Hydrolysis, Hyperlipidemias, Lipoproteins, Lipoproteins, VLDL, Male, Middle Aged, Triglycerides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.